Following calls by members of the medical fraternity in Jamaica for the use of the drug Ivermectin to fight the COVID-19 disease, the Caribbean Public Health Agency (CARPHA) says it does not support the use of the drug Ivermectin outside of well-regulated clinical trials for the treatment of COVID-19.
The agency opines that there is limited evidence available to assure a favorable benefit-risk balance in the use of the drug with patients who have had COVID-19.
CARPHA is urging Member States to heed the current advice of the World Health Organization (WHO) regardless of disease severity or duration of symptoms.
The agency stance is in keeping line with Jamaica’s government decision not to endorse the use of ivermectin for treating COVID-19 patients despite constant calls from various stakeholders.
Edited by Jesus Chan
Do you want to add feedback to this story?
Please add a comment in the box below or send email to email@example.com, send us a message on WhatsApp at 646-874-7976 or Call us at 201-500-771